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Bacteremia with fever due to a novel subspecies of Bartonella vinsonii was found in a cattle rancher. The
subspecies shared major characteristics of the genus Bartonella in terms of most biochemical features and
cellular fatty acid profile, but it was distinguishable from other subspecies of B. vinsonii by good growth on
heart infusion agar supplemented with X factor and by its pattern of enzymatic hydrolysis of peptide substrates. DNA relatedness studies verified that the isolate belonged to the genus Bartonella and that it was
genotypically related to B. vinsonii. The highest level of relatedness was observed with recently characterized
strains from naturally infected mice that were coinfected with Borrelia burgdorferi and Babesia microti. We
propose the name Bartonella vinsonii subsp. arupensis subsp. nov. as the new subspecies to accommodate these
human and murine isolates.

Bartonella vinsonii was described as the Canadian vole agent
in 1946 by Baker (1). It was further characterized by Weiss and
Dasch (17), who proposed the name Rochalimaea vinsonii in
1982. The members of the genus Rochalimaea were then reclassified as Bartonella spp. on the basis of DNA relatedness
and 16S rRNA sequence data by Brenner and coworkers in
1993 (5). B. vinsonii has not heretofore been implicated in human disease, although a subspecies (Bartonella vinsonii subsp.
berkhoffii) causing canine endocarditis was recently described
(3, 11).
The characterization of novel Bartonella species and subspecies continues (2, 7, 8, 10, 11, 13). A study originally intended
to determine the prevalence of Borrelia burgdorferi, Babesia
microti, and Ehrlichia species in Minnesota and Wisconsin
mice identified, instead of any animals infected with Ehrlichia
spp., four Bartonella-infected animals by using Ehrlichia PCR
primers (9). Analysis of the citrate synthase gene sequence of
one of the isolates showed that it was most closely related to B.
vinsonii. Prior to that report, our laboratory received an isolate
from the blood culture of a Wyoming man which we confirmed
as B. vinsonii. In light of these two findings, we were led to
compare the human isolate and the isolates from nature for
DNA relatedness as well as to describe the Wyoming man’s
case and the isolate itself.

CASE REPORT
Case history. The patient is a 62-year-old Caucasian male
who was admitted in May 1994 to a community hospital in
Wyoming with acute onset of confusion, difficulty in walking,
and facial numbness. The patient had been well 48 h prior to
admission. He is a rancher by occupation, and he had been very
active ranching and irrigating in the days prior to the onset of
symptoms. Two days prior to admission he developed some
low-grade “warm and cold” feelings and fatigue. He also experienced some dizziness, characterized as a feeling of instability when walking and doing chores. A mild headache and
myalgias, but no stiffness or photophobia, were also reported.
He took aspirin and ibuprofen for these symptoms. On the day
of admission, his legs “got stiff,” and he fell when trying to get
up from a seated position while branding cattle. He was noted
to have slurred speech and to be confused. There was no
evidence of seizure activity. The pulse was rapid and irregular.
No other symptoms were reported.
The medical history is significant for an ill-defined rheumatologic disease characterized by a high positive antinuclear
antibody level, elevated erythrocyte sedimentation rate, positive rheumatoid factor, Sjögren’s syndrome, and polyneuropathy, diagnosed in 1960 after a lengthy hospitalization in California. The rheumatologic syndrome is also characterized by
variable neurological manifestations, including aseptic meningitis. Relapses are managed by high-dose intravenous steroids.
In 1987 he was treated with prednisone for a presumed relapse
of vasculitis when he presented with vertigo, headache, and
numbness of the hands. Between exacerbations, he is relatively
asymptomatic, and he does not require long-term steroid therapy.
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TABLE 1. DNA relatedness of strain OK 94-513 to Bartonella strainsa
Bartonella strain 95 0726 14a

OK 94-513

Source of unlabeled DNA

B. vinsonii subsp. vinsonii
ATCC VR-152

% R at 55°C

%D

% R at 70°C

% R at 55°C

%D

% R at 70°C

% R at 55°C

%D

% R at 70°C

100

0.0

100

72

3.5

78

73

5.0

62

Bartonella strain 95 0726 14a
Bartonella strain 95 0726 14b
Bartonella strain 95 0726 14c

82
81
80

2.5
2.0
2.5

80
78
77

100
99
96

0.0
0.0
0.0

100
98
99

69
68
65

4.5
5.5
5.0

B. vinsonii subsp. vinsonii ATCC VR-152T
B. vinsonii subsp. berkhoffii ATCC 51672T
B. vinsonii subsp. berkhoffii 93-CO1

81
72
75

6.5
7.0
6.0

71
57
61

85
73

6.0
7.0

64

100
73
77

0.0
5.5
5.0

B. quintana ATCC VR-358T
B. henselae ATCC 49882T
B. elizabethae ATCC 49927T
B. grahamii NCTC 12860T
Bartonella doshiae NCTC 12862T
Bartonella koehlerae C29T
Bartonella clarridgeae ATCC 51734T
B. bacilliformis ATCC 35685T

60
63
68

11.0
11.0
13.5

40
40
36

65

10.0

46

42

13.0

57
52
53
50
50
52
27
23

11.5
11.0
12.0
11.0
11.0
13.5
13.5
12.5

OK 94-513

a

63
68

Bartonella 95 0726 14a, -b, and -c represent second, third, and fourth passages of the same strain. % R, percent relatedness to labeled DNA.

On admission, the patient had a temperature of 100.9°F
(38.3°C). Blood pressure was 150/90 mm Hg, the pulse was
120/min, and the respiratory rate was 16/min. He appeared
encephalopathic but in no acute distress. A skin examination
revealed no stigmata of vasculitis. Examination of the head,
eyes, ears, nose, and throat was normal. The neck was supple,
and there was no adenopathy. The heart rate was irregularly
irregular without murmurs, rubs, or gallops. The lungs were
clear to percussion and auscultation. There was no hepatosplenomegaly or mass found on abdominal examination. The
neurological examination was significant for decreased sensation in the area innervated by the right-fifth-cranial nerve.
There was a palsy of the right fourth cranial-nerve, and the gag
reflex was absent. He had bilateral diplopia and slurred speech.
There was no visual-field defect. He had hyperreflexia with
bilateral clonus. He exhibited decreased concentration and
emotional lability on mental-status examination but was otherwise fully oriented.
The peripheral leukocyte count was 8,700/l with 81% neutrophils, 8% band forms, and 10% lymphocytes; platelet count
was 166,000/l and the hematocrit was 41.3%. A cerebrospinal
fluid (CSF) analysis was performed, and there were three leukocytes, undifferentiated. CSF protein was 49 mg/dl, and glucose was 45 mg/dl (peripheral glucose, 120 mg/dl). Other CSF
study results included a serum-to-CSF immunoglobulin G ratio
of 0.31, positive oligoclonal bands, but a normal immunoglobulin G index. The erythrocyte sedimentation rate was 45 mm/h.
A chemistry screen was normal except for a serum glutamic
oxalacetic transaminase level of 53 /liter and a lactate dehydrogenase level of 190 /liter. An antinuclear antibody test was
positive, showing a 1:2,560 titer with a speckled pattern. Magnetic resonance imaging of the head showed an area of increased signal in T2-weighted images in the middle and superior portions of the pons. A computerized axial tomography
scan of the head was normal. An echocardiogram showed
moderate mitral and tricuspid insufficiency and mild aortic
insufficiency but no evidence of endocarditis. An electrocardiogram revealed atrial flutter. Blood cultures were obtained
on admission, including one set in BACTEC bottles and one in
an Isolator, which grew five colonies of a gram-negative bacillus at day 7 on chocolate agar. The organism was sent to the

microbiology laboratory of Associated and Regional University Pathologists, Inc., for identification. The organism was
identified as a Bartonella species, but not B. henselae or B.
quintana. The organism was then sent to D. F. Welch for
further characterization.
The patient initially had 24 to 36 h of temperatures as high
as 39°C; he received a single 1-g dose of ceftriaxone, after
which he defervesced. Prednisone (40 mg) was administered
for presumptive cerebral vasculitis related to Sjögren’s syndrome. Anticoagulation was begun because of the atrial flutter.
He was discharged after 7 days of hospitalization with a significant improvement in neurologic symptoms. He has gradually been tapered off steroids; persistent neurologic deficits
include mild dizziness, slight difficulty in swallowing, and mild
ophthalmoplegia. He has not required hospital admission since
1994, and he continues an active lifestyle as a rancher in rural
Montana.
MATERIALS AND METHODS
Strains. The following type strains were obtained from the American Type
Culture Collection: Bartonella henselae ATCC 49793, Bartonella quintana ATCC
51694, Bartonella vinsonii subsp. vinsonii ATCC VR-152, B. vinsonii subsp. berkhoffii ATCC 51672, and Bartonella elizabethae ATCC 49927. The isolate described in “Case history” was designated OK 94-513. Cultures were maintained
on Columbia agar supplemented with 5% defibrinated sheep blood.
DNA relatedness studies. The strains used in DNA relatedness determinations
are listed in Table 1. The methods used for isolation and purification of bacterial
DNA and the hydroxyapatite method used for DNA relatedness determinations
have been described previously (4). Divergence (D) was calculated to the nearest
0.5%. All reactions were done at least twice.
Phenotypic studies. Conventional biochemical tests and commercial panels of
biochemicals were used as described elsewhere (15, 18). Briefly, inocula were
obtained from cultures growing on Columbia blood agar that were incubated for
5 to 7 days at 35°C in 5 to 10% CO2. For determining biochemical reactivity
based on preformed enzymes, suspensions equivalent to a McFarland no. 2
turbidity standard were prepared in sterile water. A dehydrated panel containing
24 substrates (Rapid Anaerobe Panel; Dade International, Inc., West Sacramento, Calif.) was inoculated and incubated at 35°C for 4 h, after which the
results were interpreted according to the manufacturer’s directions. Suspensions
equivalent to a 0.5 McFarland turbidity standard were prepared in saline for
determining X-factor growth requirements, with strips (Difco, Detroit, Mich.)
applied to heart infusion agar, or in Trypticase soy broth for susceptibility testing
by the E-test technique (AB Biodisk, Culver City, Calif.) on Columbia blood
agar. Cellular fatty acid compositions were analyzed by gas-liquid chromatography, and immunofluorescence tests were performed as previously described (15,
19).

2600

WELCH ET AL.

J. CLIN. MICROBIOL.

TABLE 2. Differential phenotypic characteristics of the case isolate compared to those of representative strains
of other Bartonella species or subspeciesa
Test

Case isolate
OK 94-513

B. vinsonii subsp.
vinsonii ATCC VR-152

B. vinsonii subsp.
berkhoffii ATCC 51672

B. quintana
ATCC 51694

B. henselae
ATCC 49793

B. elizabethae
ATCC 49927

Growth on heart infusion agar ⫹ X factor
Twitching motility
L-Leucine-␤-naphthylamidase
L-Lysine-␤-naphthylamidase (alkaline)
L-Lysine-␤-naphthylamidase (acidic)
L-Proline-␤-naphthylamidase
L-Tryptophan-␤-naphthylamidase

⫹
⫺
⫹
⫹
⫺
⫺
⫹

w
⫺
⫹
⫹
⫺
⫺
⫹

⫺
⫺
⫹
⫹
⫹
⫹
⫹

w
⫹
⫹
⫹
⫺
⫹
⫹

⫺
⫹
⫹
⫹
⫹
⫹
⫹

⫹
⫺
⫹
⫹
w
⫺
⫹

a

⫹, positive; ⫺, negative; w, weakly positive.

RESULTS
DNA relatedness studies. Labeled DNAs from the patient
strain, OK 94-513, and from three separate passages of mouse
strain 95 0726 14a were reacted with unlabeled DNAs from
each other and from type strains of Bartonella species (Table
1). Relatedness of the patient strain and the passages of the
mouse strain was 72 to 82% at 55°C (optimal criterion for
DNA reassociation), with a D of 2.0 to 3.5%. Relatedness at
the stringent (70°C) reaction temperature was 77 to 80%. Reciprocal DNA relatedness of the human and mouse strains to
B. vinsonii subsp. vinsonii and B. vinsonii subsp. berkhoffii was
65 to 85% at 55°C, with a D of 4.5 to 7%; relatedness in 70°C
reactions was 57 to 71%. Relatedness of the human and mouse
strains to all other Bartonella species for which strains are
available (there are no strains for Bartonella talpae, Bartonella
peromysci, and Bartonella taylorii) was 23 to 68% at 55°C, with
a D of 10 to 13.5%. Similar results were obtained when labeled
DNAs from the type strains of B. vinsonii subsp. vinsonii (Table
1) and B. vinsonii subsp. berkhoffii were used.
Phenotypic characterization of isolate. The organism was
initially recognized as a fastidious, small, gram-negative rod,
based on its Gram staining properties and its recovery on
chocolate agar after 7 days of incubation in an Isolator-processed blood culture. It was catalase and oxidase negative, and
it was unreactive with immunodiagnostic reagents specific for
Brucella, Francisella, B. henselae, and B. quintana. The cellular
fatty acid profile was consistent with Bartonella spp., however,
characterized by a large amount (⬃50%) of C18:17C and only
four other cellular fatty acids in significant amounts: C16:0,
13%; C17:0, 9%; C17:16C, 3%; and C18:0, 16%.
Biochemical analysis with preformed enzyme-dependent
substrate utilization assays revealed reactivity with substrates
bis p-nitrophenyl-phosphate, L-leucine-␤-naphthylamide, Llysine-␤-naphthylamide (alkaline), glycylglycine-␤-naphthylamide, glycine-␤-naphthylamide, L-arginine-␤-naphthylamide,
L-tryptophan-␤-naphthylamide, and DL-methionine-␤-naphthylamide (weakly positive); there was no reactivity with substrates
p-nitrophenyl-␤-D-galactopyranoside, p-nitrophenyl-␣-D-galactopyranoside, p-nitrophenyl-N-actelyl-␤- D -glucosaminide,
p-nitrophenyl-␣-D-glucopyranoside, p-nitrophenyl-␤-D-glucopyranoside, p-nitrophenyl-phosphate, p-nitrophenyl-␣L -fucopyranoside, p-nitrophenyl-␣- D -mannopyranoside, L lysine-␤-naphthylamide (acid), L -prolyl-␤-naphthylamide,
L-pyrrolindonyl-␤-naphthylamide, 3-indoxyl phosphate, trehalose, urea, indole, and nitrate. A comparison of these results
with those which could help distinguish other Bartonella species or subspecies is shown in Table 2. Also shown in Table 2
are the results of motility testing by wet mount and growth tests
on heart infusion agar plus X factor, which also distinguish the
isolate from B. henselae and from B. quintana, although the
latter grew weakly in the presence of the X factor.

The isolate displayed in vitro susceptibility (MIC ⬍ 0.5 g/
ml) to ampicillin, penicillin, cefotaxime, ciprofloxacin, chloramphenicol, erythromycin, clarithromycin, and tetracycline.
The MIC of gentamicin was 3.0 g/ml.
DISCUSSION
The exact contribution of the Bartonella isolate to this patient’s illness is unclear. He clearly was bacteremic, and he
clearly had very high fever. The infection may have prompted
a relapse of the vasculitis and the associated neurologic manifestations of his ill-defined rheumatologic syndrome. Occupational exposure seems to have been the likely means of acquiring the infection. There is anecdotal evidence of an abundance
of voles in the locales of Montana in which this man worked.
Ample opportunity probably existed for ectoparasitic exposure
(ticks, fleas, and biting flies), but none was documented.
In a few parts of the United States where rodent populations
have been studied, Bartonella spp. have been found to be
prevalent among mice and rats. Kosoy et al. (12) detected
Bartonella in roughly 50% of the rodent populations in the
southeastern United States, and Hofmeister et al. (9) detected
a novel Bartonella species in the blood of mice in Minnesota
and Wisconsin in the course of studies on the reservoirs of
tick-borne pathogens. The new Bartonella species was detected
incidentally, along with Borrelia burgdorferi and Babesia microti, when PCR primers targeting Ehrlichia spp. resulted in
the amplification of Bartonella-like 16S ribosomal DNA segments. These findings, as well as those of this case, suggest that
Bartonella spp. may occasionally be transmitted by ticks. Prior
to the current understanding of the epidemiology of cat scratch
disease, Lucey et al. (14) reported two cases of bacteremia due
to B. henselae in immunocompetent men who had sustained
tick bites prior to their illnesses. In addition to the well-documented role of fleas in the transmission of B. henselae (6) and
the classic examples of louse-borne trench fever due to B.
quintana and oroya fever due to Bartonella bacilliformis acquired from sand flies, it is possible that more than one arthropod vector of Bartonella-associated diseases exists.
The Bartonella strains isolated from mice by Hofmeister et
al. (9) were most closely related to Bartonella grahamii (2) on
the basis of 16S rRNA sequence analysis and were most closely
related to B. vinsonii subsp. vinsonii on the basis of citrate
synthase gene sequence analysis. Our DNA relatedness studies
indicated that mouse isolate 95 0726 14a from the study of
Hofmeister et al. and human strain OK 94-513 fulfilled the
molecular definition of a species as strains with 70% or more
DNA relatedness (at an optimal reassociation criterion) and a
D of 5% or less within related sequences (16). On the basis of
this definition, the human and mouse strains were easily differentiated from all Bartonella species other than B. vinsonii.
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The relatedness to B. vinsonii subsp. vinsonii and B. vinsonii
subsp. berkhoffii was at the species level, except that D was
almost always 5 to 7%. These data left us with the choice of
creating a new species for these strains or creating a third
subspecies for them within B. vinsonii. We chose the second
alternative because of the similarity of relatedness of the new
strains to that previously seen within existing B. vinsonii subspecies (11). We therefore now describe Bartonella vinsonii
subsp. arupensis subsp. nov.
Description of B. vinsonii subsp. arupensis subsp. nov. Bartonella vinsonii subsp. arupensis (a.rup.en.⬘sis. N.L. fem.adj.
arupensis, from Associated and Regional University Pathologists, Inc., the laboratory where the type strain was initially
characterized). Exhibits characteristics of the species B. vinsonii. Grows on heart infusion agar in the presence of X factor.
Catalase, oxidase, and motility negative. Does not react with
monospecific antisera to B. henselae or B. quintana. Biochemical characteristics that may be used to distinguish it from other
Bartonella spp. are shown in Table 2. Isolated from a human
and mice (Peromyscus leucopus). Presumptively pathogenic for
humans.
The type strain is OK 94-513 (⫽ ATCC 700727), isolated
from a 62-year-old bacteremic man.
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